Cite

HARVARD Citation

    Roche, N. et al. (2016). Cost-Effectiveness of Asthma Step-Up Therapy as an Increased Dose of Extrafine-Particle Inhaled Corticosteroid or Add-On Long-Acting Beta2-Agonist. Pulmonary therapy. 2 (1), pp. 73-89. [Online]. 
  
Back to record